logo

Incyte Corporation (INCY)



Trade INCY now with
  Date
  Headline
8/26/2022 10:02:40 AM Incyte : FDA Approves Pemazyre As Targeted Treatment For Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement
8/2/2022 7:09:50 AM Incyte Q2 GAAP EPS $0.72; Non-GAAP EPS $1.01
5/20/2022 8:19:00 AM Lilly : CHMP Issues Positive Opinion For OLUMIANT For Treatment Of Adults With Severe Alopecia Areata
5/11/2022 6:51:49 AM Lilly And Incyte: FDA Approves OLUMIANT For Certain Hospitalized Patients With COVID-19
5/3/2022 7:10:46 AM Incyte Q1 GAAP EPS $0.17; Non-GAAP EPS $0.55